27 May 2015

Cyclo-Progynova (Estradiol valerate / Norgestrel) - United Kingdom

ATC: G03FB
GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
PROGESTOGENS AND ESTROGENS IN COMBINATION
PROGESTOGENS AND ESTROGENS, SEQUENTIAL PREPARATIONS
Cyclo-Progynova

Last Updated on 27 May 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Cyclo-Progynova Indication

Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in perimenopausal and postmenopausal women.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

 

Cyclo-Progynova Generic Name

Estradiol valerate / Norgestrel

Type

POM

Summary Product Characteristics (SPCs) Links
SPC - Cyclo-Progynova 2mg (external site)

Related Learning Zones

Bedwetting Knowledge Centre and CME

Bedwetting Knowledge Centre and CME

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and a CME activity ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

Oral Anticoagulation Reversal Knowledge Centre

Oral Anticoagulation Reversal Knowledge Centre

The Oral Anticoagualtion Reversal Knowledge Centre is intended to provide healthcare professionals with accurate information on the approaches to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding, or require surgery. Content is arranged within illustrated and referenced sections including management of bleeding risk, oral anticoagulants, symposium highlights, key publication summaries and more.

This resource is developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring.

This resource is not intended for healthcare professionals outside Europe.

Cyclo-Progynova Marketing Information

Cyclo-Progynova Generic Name
Estradiol valerate / Norgestrel
Marketing Company
Meda Pharmaceuticals Ltd
Drug Type
POM
Date of Issue, Marketing Authority 01/12/2009

Related Drugs - Women's Health and Obs/Gyn

Back to top